| 标题 |
Phase III Study of Daratumumab/rhuph20 (nsc- 810307) + Lenalidomide or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapyin Patients with Multiple Myeloma (mm) Using Minimal Residual Disease Todirect Therapy Duration (DRAMMATIC study): SWOG s1803 |
| 网址 | |
| DOI |
10.1182/blood-2020-142913
doi
|
| 其它 |
期刊:Blood 作者:Amrita Krishnan; Antje Hoering; Parameswaran Hari; Rachael Sexton; Robert Z. Orlowski 出版日期:2020-11-05 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)